Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726167 · ClinicalTrials.gov registry record
Serum Procalcitonin Study in the Management of Ventilated Patients
A clinical trial, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- 29
- Enrollment target
NCT00726167 is a clinical trial that has completed, run by University of Missouri-Columbia. The registered enrollment target is 29 participants.
The verdict
NCT00726167 has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new method for diagnosing and monitoring Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method requires analysis of a small amount of the patient's blood for concentration of a hormone called Procalcitonin.
Interventions
- DEVICE Procalcitonin Level
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2008-09 |
| Est. Completion | 2014-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00726167
The ClinicalTrials.gov registry entry for NCT00726167 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Procalcitonin Level is the first listed.
NCT00726167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00726167 about?
NCT00726167 is a clinical study titled "Serum Procalcitonin Study in the Management of Ventilated Patients". The purpose of this study is to test a new method for diagnosing and monitoring Ventilator-Associated Pneumonia, which is a major killer among ICU patients. The method requires analysis of a small amount of the patient's blood for concentration of a hormone called Procalcitonin.
What is the current status of trial NCT00726167?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2008-09. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00726167?
The interventions under investigation include: Procalcitonin Level (DEVICE).
Who is sponsoring clinical trial NCT00726167?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.